166 related articles for article (PubMed ID: 19861440)
21. Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.
Somuncu B; Ekmekcioglu A; Antmen FM; Ertuzun T; Deniz E; Keskin N; Park J; Yazici IE; Simsek B; Erman B; Yin W; Erman B; Muftuoglu M
PLoS One; 2022; 17(6):e0268391. PubMed ID: 35657956
[TBL] [Abstract][Full Text] [Related]
22. Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis.
Avdievich E; Reiss C; Scherer SJ; Zhang Y; Maier SM; Jin B; Hou H; Rosenwald A; Riedmiller H; Kucherlapati R; Cohen PE; Edelmann W; Kneitz B
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4247-52. PubMed ID: 18337503
[TBL] [Abstract][Full Text] [Related]
23. Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.
Tentori L; Leonetti C; Muzi A; Dorio AS; Porru M; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Int J Oncol; 2013 Jul; 43(1):210-8. PubMed ID: 23653048
[TBL] [Abstract][Full Text] [Related]
24. MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.
Ding X; Mohd AB; Huang Z; Baba T; Bernardini MQ; Lyerly HK; Berchuck A; Murphy SK; Buermeyer AB; Devi GR
Br J Cancer; 2009 Jul; 101(2):269-77. PubMed ID: 19603033
[TBL] [Abstract][Full Text] [Related]
25. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.
Stubbert LJ; Smith JM; McKay BC
BMC Cancer; 2010 May; 10():207. PubMed ID: 20470425
[TBL] [Abstract][Full Text] [Related]
26. A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells.
Zeng X; Kinsella TJ
Autophagy; 2007; 3(4):368-70. PubMed ID: 17426439
[TBL] [Abstract][Full Text] [Related]
27. MLH1 function is context dependent in colorectal cancers.
Jackson T; Ahmed MA; Seth R; Jackson D; Ilyas M
J Clin Pathol; 2011 Feb; 64(2):141-5. PubMed ID: 21169277
[TBL] [Abstract][Full Text] [Related]
28. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae.
Kalimutho M; Bain AL; Mukherjee B; Nag P; Nanayakkara DM; Harten SK; Harris JL; Subramanian GN; Sinha D; Shirasawa S; Srihari S; Burma S; Khanna KK
Mol Oncol; 2017 May; 11(5):470-490. PubMed ID: 28173629
[TBL] [Abstract][Full Text] [Related]
29. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
[TBL] [Abstract][Full Text] [Related]
30. A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene.
Blasi MF; Ventura I; Aquilina G; Degan P; Bertario L; Bassi C; Radice P; Bignami M
Cancer Res; 2006 Sep; 66(18):9036-44. PubMed ID: 16982745
[TBL] [Abstract][Full Text] [Related]
31. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB
J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298
[TBL] [Abstract][Full Text] [Related]
32. Signalling cell cycle arrest and cell death through the MMR System.
O'Brien V; Brown R
Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
[TBL] [Abstract][Full Text] [Related]
33. Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1.
He W; Zhao Y; Zhang C; An L; Hu Z; Liu Y; Han L; Bi L; Xie Z; Xue P; Yang F; Hang H
Nucleic Acids Res; 2008 Nov; 36(20):6406-17. PubMed ID: 18842633
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays.
Takahashi M; Shimodaira H; Andreutti-Zaugg C; Iggo R; Kolodner RD; Ishioka C
Cancer Res; 2007 May; 67(10):4595-604. PubMed ID: 17510385
[TBL] [Abstract][Full Text] [Related]
35. Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2.
Pitsikas P; Lee D; Rainbow AJ
Mutagenesis; 2007 May; 22(3):235-43. PubMed ID: 17351251
[TBL] [Abstract][Full Text] [Related]
36. Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance.
de las Alas MM; Aebi S; Fink D; Howell SB; Los G
J Natl Cancer Inst; 1997 Oct; 89(20):1537-41. PubMed ID: 9337351
[TBL] [Abstract][Full Text] [Related]
37. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
[TBL] [Abstract][Full Text] [Related]
38. Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.
Fedier A; Erdmann R; Boulikas T; Fink D
Int J Oncol; 2006 Nov; 29(5):1303-10. PubMed ID: 17016665
[TBL] [Abstract][Full Text] [Related]
39. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
40. Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice.
Morioka T; Miyoshi-Imamura T; Blyth BJ; Kaminishi M; Kokubo T; Nishimura M; Kito S; Tokairin Y; Tani S; Murakami-Murofushi K; Yoshimi N; Shimada Y; Kakinuma S
Cancer Sci; 2015 Mar; 106(3):217-26. PubMed ID: 25529563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
